Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Calorie restriction & fasting
Video summary

Video description: five intermittent fasting claims checked against cited research

The description says five common intermittent fasting claims were checked against the actual studies, separating published human research from mouse findings presented as human health claims. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The creator says five common intermittent fasting claims were each checked against the actual studies, not infographic summaries. [1]

  2. The description says some claims are published, peer-reviewed science while others are a mouse study presented as a human health claim. [1]

  3. The description cites a 2022 meta-analysis comparing intermittent fasting with continuous calorie restriction and a 2024 meta-analysis of 10 randomized controlled trials. [1]

The source at a glance

Study type / format
Video description with a reference list
Population / context
Intermittent fasting claims and the studies cited in the video description
Summary based on
Creator description
Original publication
September 11, 2026

Five fasting claims checked against cited studies

The creator says intermittent fasting has been credited with everything from faster fat loss to slowing aging. The description states that five of the most common claims were each checked against the actual research rather than infographic summaries. It also says some claims are real, published, peer-reviewed science, while others are a mouse study presented as a human health claim. The description does not say which of the five claims fell into which group.

Supporting source [1]

Cited comparisons: fasting versus calorie restriction and TREAT

The reference list names a 2022 meta-analysis by Nguyen and colleagues in Nutrients comparing intermittent fasting with continuous calorie restriction, and a 2024 meta-analysis of 10 randomized controlled trials on the same comparison. It also cites the TREAT trial by Lowe and colleagues (2020, JAMA Internal Medicine), described as a 12-month trial, and a 2022 New England Journal of Medicine entry on time-restricted eating plus resistance training preserving lean mass. The description gives no effect sizes or results for these entries.

Supporting source [1]

Autophagy, glucose and stated skepticism in the description

The description lists references on autophagy and fasting duration in humans and on early time-restricted feeding and glucose independent of weight loss, both via PMC, plus MedicineNet (2025) and Scinergy (2026). It also notes that Jeff Cavaliere (Athlean-X) publicly stated skepticism about intermittent fasting's long-term practicality. The video is voiced with AI narration and is described as general education, not medical advice.

Supporting source [1]

How to interpret this

Only the video description was available; the video and transcript were not reviewed. The description names references but reports no results, effect sizes or which claims were supported, and its safety or efficacy implications cannot be verified from it.

Based on the creator’s description; the full video and transcript were not analyzed.

Source & supporting passages

[1]
1 in 5 Intermittent Fasting Claims Actually Survives the Research

The ROI Of Health · youtube.com · September 11, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    checked each one against the actual research
  2. Finding 2 ↑

    a mouse study wearing a human health
  3. Finding 3 ↑

    IF vs. CCR (2024 meta-analysis, 10 RCTs)

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…